Core Laboratories Inc. /De/ (CLB) Stock Price & Analysis
Core Laboratories Inc. /De/ (CLB) fell 1.19% to USD 13.27 as of June 10, 2026 at 02:21 UTC, according to Nexqual real-time market data.
CLB last closed at USD 13.43; the session ranged USD 12.82–13.39 on volume of 777,908 shares. Market capitalization is $611.70M, with a 52-week range of USD 9.72–20.36 (NYQ). Source: Nexqual, June 10, 2026 at 02:21 UTC.
Key Statistics (as of June 10, 2026 at 02:21 UTC)
| Price | USD 13.27 |
|---|---|
| Change | ▼ 1.19% (down) |
| Previous Close | USD 13.43 |
| Open | USD 13.3 |
| Day Range | USD 12.82 – 13.39 |
| 52-Week Range | USD 9.72 – 20.36 |
| Volume | 777,908 shares |
| Market Cap | $611.70M |
| Exchange | NYQ |
Technical Analysis (CLB)
Nexqual's technical model rates CLB "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:21 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.34 (neutral) |
| vs SMA50 | Below (USD 15.04) |
| MACD | -0.43 (negative) |
Analyst Ratings (CLB)
Wall Street analysts rate CLB "None" based on 3 analysts, with a mean price target of USD 16.33 (range USD 12–22), per Nexqual as of June 10, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 16.33 |
| High Target | USD 22 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 1 / 1 / 1 |
Earnings (CLB)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 0.09 |
| Revenue Estimate | $127.05M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.06 vs est 0.11 ▼ miss |
| 2025-12-31 | USD 0.21 vs est 0.19 ▲ beat |
| 2025-09-30 | USD 0.22 vs est 0.19 ▲ beat |
| 2025-06-30 | USD 0.19 vs est 0.18 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financials & Fundamentals (CLB)
| Total Revenue | $524.73M |
|---|---|
| Revenue Growth (YoY) | -1.40% |
| Gross Margin | +19.92% |
| Operating Margin | +1.62% |
| Profit Margin | +5.53% |
| ROE | +11.06% |
| Debt / Equity | 61 |
| Current Ratio | 2.05 |
| Total Cash | $22.82M |
| Total Debt | $167.84M |
| Free Cash Flow | $44.22M |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Financial Health Score (CLB)
Nexqual rates Core Laboratories Inc. /De/'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:21 UTC.
| Growth | Mixed — Revenue +0.5% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 20%, operating 2% |
| Balance Sheet | Strong — $23M cash vs $168M debt |
| Cash Flow | Solid — FCF $44M, 8% margin |
| Efficiency | Mixed — ROE 11%, ROA 4.9% |
Ownership (CLB)
| Insider Ownership | +1.43% |
|---|---|
| Institutional Ownership | +113.72% |
| Shares Outstanding | 46.10M |
| Float | 45.42M |
| Short % of Float | +29.50% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
Leadership (CLB)
Core Laboratories Inc. /De/ is led by Lawrence V. Bruno (age 65), Chairman of the Board, CEO, President & COO, per Nexqual as of June 10, 2026 at 02:21 UTC.
| Chairman of the Board, CEO, President & COO | Lawrence V. Bruno (age 65) |
|---|---|
| Senior VP & CFO | Christopher Scott Hill (age 55) |
| Senior Vice President of Corporate Development & Investor Relations | Gwendolyn Y. Gresham (age 57) |
| Vice President of People, Organization & Culture | Leslie D. Linklater |
| Senior Vice President of Production Enhancement & Business Development | J. Donald Dumas |
Major Backers & Investors (CLB)
Notable institutional backers of Core Laboratories Inc. /De/ include Ariel Investments, LLC, Ariel Investment Trust-Ariel Fund, Disciplined Growth Investors, Inc., according to Nexqual as of June 10, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Ariel Investments, LLC | 28.57% |
| Ariel Investment Trust-Ariel Fund | 15.02% |
| Disciplined Growth Investors, Inc. | 10.71% |
| Earnest Partners LLC | 6.63% |
| CWA Asset Management Group, LLC | 3.78% |
| HARBOR FUNDS-Harbor Small Cap Value Fund | 2.51% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 25.16% |
| Vanguard Group | 9.67% |
| State Street | 5.39% |
| Dimensional Fund Advisors | 2.93% |
Source: Nexqual, June 10, 2026 at 02:21 UTC.
From Core Laboratories Inc. /De/'s Latest SEC 10-K Filing (filed 2026-03-23)
Key Strengths & Strategy (as disclosed to the SEC)
- We were established in 1936 and are one of the world's leading providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, primarily through client relationships with many of the world's major, national and independent oil companies.
- While we have patented some of our key technologies, we do not patent all of our proprietary technology even where regarded as patentable.
- We also use our proprietary services and technologies to correlate the reservoir description data to wireline logs and other subsurface data.
- This global emphasis allows us to increase our revenue and enhance our profit through efficient utilization of our worldwide network.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OII | Oceaneering International, Inc. | USD 39.01 | ▲ 5.01% |
| FTI | TechnipFMC plc | USD 68.39 | ▲ 2.35% |
| RES | RPC, Inc. | USD 6.96 | ▲ 2.2% |
| OIS | Oil States International, Inc. | USD 8.39 | ▲ 3.33% |
| NOV | NOV Inc. | USD 20.82 | ▲ 3.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:21 UTC. This page is informational and not investment advice.